A Study of Dexlansoprazole Modified Release (MR) in Gastroesophageal Reflux Disease (GERD) Participants in the Russian Federation
Condition: Gastroesophageal Reflux Disease Intervention: Sponsor: Takeda Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Acid Reflux | Dexilant | Gastroenterology | Gastroesophageal Reflux Disease | GERD | Research | Russia Health | Study